Literature DB >> 2109714

Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.

D V Serreze1, E H Leiter, L D Shultz.   

Abstract

F1 hybrids produced by outcross of non-obese diabetic (NOD) mice with diabetes resistant strains are also diabetes resistant. This resistance is abrogated if F1 hybrids are lethally irradiated and then haematopoietically reconstituted with NOD bone marrow. This model was employed to determine whether T lymphocyte recognition and elimination of pancreatic B cells in NOD mice is restricted by the MHC haplotype of the target B cell. Diabetes resistant (NOD/Lt x CBA/J)F1 hybrids were lethally irradiated and reconstituted with NOD/Lt bone marrow. Following haematopoietic reconstitution, donor matched NOD/Lt or CBA/J pancreatic islet and anterior pituitary grafts were grafted under a renal capsule to determine whether effector cells derived from NOD/Lt marrow progenitors would reject islet grafts in a MHC restricted fashion. The H-2k haplotype expressed by CBA/J mice differs from all known loci of the unique H-2 haplotype of NOD; therefore, if NOD/Lt T lymphocytes eliminate pancreatic B cells in a MHC restricted fashion. NOD islet grafts would be eliminated in these chimeras while CBA islet grafts would be retained. Overt diabetes developed in 80% of the female and 40% of the male F1 hybrids following reconstitution with NOD/Lt marrow, while no hybrids reconstituted with CBA/J marrow became diabetic through a year of age. The retention of CBA/J skin and pituitary grafts in NOD/Lt marrow reconstituted F1 hybrids confirmed that the F1 thymic environment imparted tolerance to CBA/J alloantigens. Nonetheless, responses to a T cell dependent model antigen were restricted to the unique MHC haplotype of NOD. This was associated in the hyperglycaemic chimeras with rejection (8-21 days post-implantation) of both CBA/J and NOD/Lt islet grafts.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2109714     DOI: 10.1007/bf00401045

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  High-glucose stimulation of 64,000-Mr islet cell autoantigen expression.

Authors:  O Kämpe; A Andersson; E Björk; A Hallberg; F A Karlsson
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

2.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.

Authors:  H Acha-Orbea; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 3.  Mechanisms of pancreatic beta-cell destruction in type I diabetes.

Authors:  J Nerup; T Mandrup-Poulsen; J Mølvig; S Helqvist; L Wogensen; J Egeberg
Journal:  Diabetes Care       Date:  1988 Nov-Dec       Impact factor: 19.112

4.  Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.

Authors:  T Koike; Y Itoh; T Ishii; I Ito; K Takabayashi; N Maruyama; H Tomioka; S Yoshida
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

5.  NOD marrow stem cells adoptively transfer diabetes to resistant (NOD x NON)F1 mice.

Authors:  D V Serreze; E H Leiter; S M Worthen; L D Shultz
Journal:  Diabetes       Date:  1988-02       Impact factor: 9.461

6.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.

Authors:  B J Miller; M C Appel; J J O'Neil; L S Wicker
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

7.  Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody.

Authors:  M Harada; S Makino
Journal:  Jikken Dobutsu       Date:  1986-10

8.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01

9.  The effect of H-2 compatibility on pancreatic beta cell survival in the nonobese diabetic mouse.

Authors:  M Terada; M Salzler; K Lennartz; Y Mullen
Journal:  Transplantation       Date:  1988-03       Impact factor: 4.939

10.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  5 in total

1.  Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice.

Authors:  H R Gaskins; M Prochazka; K Hamaguchi; D V Serreze; E H Leiter
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 2.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

3.  Abnormal T cell selection on nod thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice.

Authors:  V Thomas-Vaslin; D Damotte; M Coltey; N M Le Douarin; A Coutinho; J Salaün
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

4.  Autoimmune polyendocrine failure--type 1 (insulin-dependent) diabetes mellitus and hypothyroidism--after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia.

Authors:  B Vialettes; D Maraninchi; M P San Marco; F Birg; A M Stoppa; C Mattei-Zevaco; C Thivolet; L Hermitte; P Vague; P Mercier
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

5.  The Type 1 Diabetes-Resistance Locus Idd22 Controls Trafficking of Autoreactive CTLs into the Pancreatic Islets of NOD Mice.

Authors:  Robert L Whitener; Lisa Gallo Knight; Jianwei Li; Sarah Knapp; Shuyao Zhang; Mani Annamalai; Vadim M Pliner; Dongtao Fu; Ilian Radichev; Christina Amatya; Alexei Savinov; Arif Yurdagul; Shuai Yuan; John Glawe; Christopher G Kevil; Jing Chen; Scott E Stimpson; Clayton E Mathews
Journal:  J Immunol       Date:  2017-11-06       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.